We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$910M
AUM Growth
+$303M
Cap. Flow
+$298M
Cap. Flow %
32.79%
Top 10 Hldgs %
6.34%
Holding
2,256
New
789
Increased
455
Reduced
377
Closed
581
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROKU icon
1
CALL
Roku
ROKU
$21B
$6.68M 0.73%
73,800
+50,500
+217% +$4.05M
SRE icon
2
CALL
Sempra
SRE
$61.1B
$6.12M 0.67%
89,000
+50,000
+128% +$3.28M
IQV icon
3
CALL
IQVIA
IQV
$34.6B
$6.03M 0.66%
37,500
+24,200
+182% +$3.4M
WAT icon
4
CALL
Waters Corp
WAT
$37.5B
$5.9M 0.65%
27,400
+20,400
+291% +$4.46M
AGN
5
CALL
DELISTED
Allergan plc
AGN
$5.79M 0.64%
34,600
+23,700
+217% +$3.28M
ZTS icon
6
CALL
Zoetis
ZTS
$31.3B
$5.74M 0.63%
50,600
+29,100
+135% +$3.05M
HLT icon
7
CALL
Hilton Worldwide
HLT
$72.9B
$5.66M 0.62%
57,900
+39,100
+208% +$3.55M
ABBV icon
8
CALL
AbbVie
ABBV
$454B
$5.55M 0.61%
76,300
+30,100
+65% +$2.37M
MRK icon
9
CALL
Merck
MRK
$322B
$5.12M 0.56%
64,033
+23,999
+60% +$1.84M
LUMN icon
10
CALL
Lumen
LUMN
$6.73B
$5.09M 0.56%
432,700
+326,100
+306% +$3.67M
TMO icon
11
CALL
Thermo Fisher Scientific
TMO
$213B
$5.05M 0.56%
17,200
+7,900
+85% +$2.18M
VRTX icon
12
CALL
Vertex Pharmaceuticals
VRTX
$120B
$5.03M 0.55%
27,400
+17,100
+166% +$2.99M
BMY icon
13
CALL
Bristol-Myers Squibb
BMY
$126B
$4.97M 0.55%
109,500
+106,300
+3,322% +$4.95M
MAR icon
14
CALL
Marriott International
MAR
$96.1B
$4.49M 0.49%
+32,000
New +$4.25M
GRMN
15
CALL
Garmin
GRMN
$46.3B
$4.43M 0.49%
55,500
+54,200
+4,169% +$4.43M
LLY icon
16
CALL
Eli Lilly
LLY
$1.06T
$4.42M 0.49%
39,900
+33,400
+514% +$3.93M
SO icon
17
CALL
Southern Company
SO
$109B
$4.39M 0.48%
79,500
+72,200
+989% +$3.87M
RGEN icon
18
CALL
Repligen
RGEN
$7.76B
$4.39M 0.48%
51,100
+45,000
+738% +$3.07M
STT icon
19
CALL
State Street
STT
$50.6B
$4.19M 0.46%
+74,700
New +$4.64M
CPAY icon
20
CALL
Corpay
CPAY
$23.8B
$4.1M 0.45%
14,600
+6,800
+87% +$1.78M
PPLI
21
CALL
People Inc
PPLI
$3.14B
$3.87M 0.43%
99,598
+41,965
+73% +$1.67M
CBRL icon
22
CALL
Cracker Barrel
CBRL
$1.16B
$3.77M 0.41%
+22,100
New +$3.62M
BIIB icon
23
CALL
Biogen
BIIB
$29.6B
$3.72M 0.41%
15,900
+14,900
+1,490% +$3.44M
XRAY icon
24
CALL
Dentsply Sirona
XRAY
$2.55B
$3.64M 0.4%
62,300
+56,300
+938% +$3.03M
LOW icon
25
CALL
Lowe's Companies
LOW
$113B
$3.59M 0.39%
35,600
+34,900
+4,986% +$3.68M

Similar funds

Walleye Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Walleye Capital held 2,256 positions worth $910M, up 50% from $607M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Walleye Capital deployed $298M of net new capital in Q2 2019, opening 789 new positions and adding to 455 existing holdings. Its largest new stake was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.

By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, an estimated $1.87M trimmed.

  • Walleye Capital's largest Q2 2019 buy was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
  • Walleye Capital added most to Cronos Group in Q2 2019, an estimated $727K increase.
  • Walleye Capital's biggest Q2 2019 reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, cutting an estimated $1.87M.
  • Walleye Capital fully exited Pivotal Acquisition Corp. in Q2 2019, selling an estimated $1.27M.
  • Walleye Capital's ten largest holdings make up 6.3% of its $910M portfolio in Q2 2019.
  • Walleye Capital opened 789 new positions and closed 581 in Q2 2019.
  • Walleye Capital's portfolio value rose 50% quarter-over-quarter to $910M.

Based on Walleye Capital's 13F filing for Q2 2019, filed 14 Aug 2019.